Tag: Heart failure

July 25, 2019

Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference

Cardiol Therapeutics Inc. (TSX:CRDL, OTCQX:CRTPF) ("Cardiol" or the "Company"), focused on producing pharmaceutical CBD products and developing innovative therapies for...
June 20, 2019

Cardiol Therapeutics Announces Plans for Orphan Drug Program in Acute Myocarditis with CardiolRx CBD Formulation

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company") is pleased to announce that the Company is planning...
June 3, 2019

Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD

Cardiol Therapeutics Inc. (TSX:CRDL, OTCQX:CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical cannabidiol (CBD)...
May 30, 2019

Cardiol Therapeutics Commences Trading on the OTCQX

Cardiol Therapeutics Inc. (TSX:CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical...
April 30, 2019

Cardiol is a Leader in Pharmaceutically Pure CBD

Cardiol Therapeutics Inc. (TSX:CRDL,OTC:CRTPF) was featured in an article by Technical420 which covered the shift away from cannabis cultivation into a...
March 28, 2019

Cardiol Therapeutics Announces Filing of Year-End Financial Statements and MD&A

Cardiol Therapeutics Inc. (TSX:CRDL) ("Cardiol" or the "Company"), a leader in the research and development of pharmaceutical cannabidiol and targeted...
March 12, 2019

Cardiol Therapeutics to Present at the 2019 LD Micro Virtual Conference

Cardiol Therapeutics Inc. (TSX:CRDL) (OTC:CRTPF), a leader in the research and commercial development of pharmaceutical cannabidiol products and targeted therapies for...